I've spent 15+ years building federated data platforms for healthcare, where privacy-by-design isn't just marketing speak--it's literally life or death for patient trust. The Meta-Flo verdict highlights what we've been screaming about in healthcare tech: you can't just hoover up sensitive data and claim "legitimate interest" when people's most private moments are involved. At Lifebit, we handle genomic and reproductive health data across multiple countries, and we learned early that true privacy means computation goes to the data, not the other way around. When researchers want to analyze fertility patterns across our network, they run algorithms on distributed datasets without ever seeing raw patient information--complete opposite of Meta's approach of centralizing everything. The scary part about this verdict is how it exposes the fertility tracking ecosystem. We've seen pharmaceutical companies abandon promising women's health research because they couldn't guarantee data sovereignty across jurisdictions. Now imagine if Meta had been feeding that hoovered Flo data into their ad targeting algorithms--suddenly your fertility struggles become profit centers. This case will definitely embolden more class actions against health app data practices. The plaintiffs proved economic harm from privacy violations, which is usually the hardest part. Expect fertility, mental health, and genetic testing apps to get hit next--especially ones with murky consent flows or third-party data sharing.